发明名称 |
Epoprostenol formulation and method of making thereof |
摘要 |
This invention relates to a stable epoprostenol composition that can be combined with commercially available IV fluids and can be administered in its reconstituted and/or diluted form under ambient conditions of about 15-30° C. for greater than 24 hours. The composition preferably contains (a) epoprostenol or a salt thereof; (b) a alkalinization agent; and (c) a base, such that when reconstituted or in solution, the solution has a pH>11. Methods for making the lyophilized composition are also disclosed. |
申请公布号 |
US8598227(B2) |
申请公布日期 |
2013.12.03 |
申请号 |
US201213621489 |
申请日期 |
2012.09.17 |
申请人 |
PALEPU NAGESH R.;ACTELION PHARMACEUTICALS LTD. |
发明人 |
PALEPU NAGESH R. |
分类号 |
A01N43/00;A01N43/06;A61K31/33;A61K31/38 |
主分类号 |
A01N43/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|